phosphatidylcholines has been researched along with Pneumococcal Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, C; Freyer, D; Küster, C; Pfeil, D; Reiss, A; Schröder, NW; Schumann, RR; Tuomanen, EI; Weber, JR | 1 |
Jackowski, S; Smith, SH; Tuomanen, EI; Van Der Merwe, M; Weber, JR; Zweigner, J | 1 |
Briles, DE; Dillon, HC; Gray, BM | 1 |
Cote, DN; Nemechek, AJ; Pahlavan, N | 1 |
4 other study(ies) available for phosphatidylcholines and Pneumococcal Infections
Article | Year |
---|---|
Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein.
Topics: Acute-Phase Proteins; Animals; Binding Sites; Carrier Proteins; Case-Control Studies; Cell Wall; Cells, Cultured; Humans; Immunity, Innate; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Models, Molecular; Nitric Oxide; Peptidoglycan; Phosphatidylcholines; Pneumococcal Infections; Rats; Receptors, Cell Surface; Signal Transduction; Streptococcus pneumoniae; Toll-Like Receptors; Transfection; Tumor Necrosis Factor-alpha | 2003 |
Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain.
Topics: Animals; Apoptosis; Cell Line; Cytidine Diphosphate Choline; Hippocampus; Humans; Lysophosphatidylcholines; Mice; Microglia; Neurons; Nootropic Agents; Phosphatidylcholines; Pneumococcal Infections; Rats; Streptococcus pneumoniae | 2004 |
Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.
Topics: Age Factors; Antibody Formation; Child, Preschool; Epidemiologic Methods; Humans; Immunoglobulin M; Infant; Infant, Newborn; Nasopharynx; Phosphatidylcholines; Pneumococcal Infections; Radioimmunoassay; Streptococcus pneumoniae | 1983 |
Nebulized surfactant for experimentally induced otitis media with effusion.
Topics: Administration, Inhalation; Administration, Topical; Aerosols; Animals; Disease Models, Animal; Eustachian Tube; Fatty Acids, Nonesterified; Gerbillinae; Nebulizers and Vaporizers; Otitis Media with Effusion; Phosphatidylcholines; Pilot Projects; Pneumococcal Infections; Pressure; Streptococcus pneumoniae; Surface-Active Agents; Time Factors; Treatment Outcome; Triglycerides | 1997 |